Fresenius Medical Care (NYSE:FMS) Shares Gap Down - Here's What Happened

Shares of Fresenius Medical Care AG (NYSE:FMS - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $28.46, but opened at $27.30. Fresenius Medical Care shares last traded at $27.39, with a volume of 42,387 shares.

Wall Street Analysts Forecast Growth

FMS has been the topic of several recent analyst reports. Wall Street Zen initiated coverage on Fresenius Medical Care in a research note on Tuesday, May 20th. They set a "strong-buy" rating on the stock. Morgan Stanley restated an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. Finally, Truist Financial increased their target price on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the company a "hold" rating in a research report on Monday, May 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Fresenius Medical Care has an average rating of "Hold" and an average target price of $27.80.

Fresenius Medical Care Trading Down 4.3%

The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The firm has a 50-day moving average price of $26.93 and a 200-day moving average price of $24.80. The company has a market capitalization of $15.99 billion, a price-to-earnings ratio of 22.52, a PEG ratio of 0.76 and a beta of 0.88.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. Fresenius Medical Care had a return on equity of 6.04% and a net margin of 3.43%. The firm had revenue of $5.54 billion for the quarter, compared to analyst estimates of $4.71 billion. As a group, sell-side analysts predict that Fresenius Medical Care AG will post 1.51 EPS for the current year.

Fresenius Medical Care Increases Dividend

The firm also recently announced an annual dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 23rd were issued a dividend of $0.7871 per share. This represents a yield of 1.9%. This is a boost from Fresenius Medical Care's previous annual dividend of $0.44. The ex-dividend date of this dividend was Friday, May 23rd. Fresenius Medical Care's dividend payout ratio (DPR) is presently 50.89%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of FMS. Venturi Wealth Management LLC grew its holdings in shares of Fresenius Medical Care by 8.4% in the 4th quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after acquiring an additional 441 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Fresenius Medical Care by 5.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock worth $210,000 after purchasing an additional 442 shares in the last quarter. Crossmark Global Holdings Inc. raised its holdings in Fresenius Medical Care by 0.9% during the 1st quarter. Crossmark Global Holdings Inc. now owns 64,871 shares of the company's stock worth $1,615,000 after buying an additional 584 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after buying an additional 806 shares during the period. Finally, Callan Capital LLC raised its holdings in shares of Fresenius Medical Care by 6.6% during the first quarter. Callan Capital LLC now owns 13,974 shares of the company's stock valued at $348,000 after acquiring an additional 870 shares during the period. Institutional investors own 8.37% of the company's stock.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.